MBIA (MBI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for May 6, 2025, in a virtual format to ensure universal access for all shareholders.
Shareholders will vote on director elections, executive compensation (say-on-pay), auditor ratification, and an amended Omnibus Incentive Plan.
Proxy materials are available online, with options for electronic or paper delivery and multiple voting methods (internet, phone, mail, live webcast).
A quorum requires a majority of outstanding shares; each share equals one vote.
Voting matters and shareholder proposals
Proposal 1: Election of six directors for a one-year term.
Proposal 2: Advisory vote on executive compensation for named executive officers.
Proposal 3: Ratification of PricewaterhouseCoopers LLP as independent auditors for 2025.
Proposal 4: Approval of the Amended and Restated Omnibus Incentive Plan, increasing share reserve by 3 million shares.
Board of directors and corporate governance
Board consists of six directors, with a majority being independent and diverse in skills and backgrounds.
Three standing committees: Audit, Finance and Risk, and Compensation & Governance, all with independent members.
Board leadership is separated between Chairman and CEO roles.
Directors are expected to attend at least 75% of meetings and all attended the 2024 annual meeting.
Board diversity and director selection emphasize a range of experiences and backgrounds.
Latest events from MBIA
- Virtual annual meeting to vote on directors, pay, and auditors, with strong governance focus.MBI
Proxy filing23 Mar 2026 - 2025 net losses narrowed, PREPA exposure reduced, and investor call set for February 27, 2026.MBI
Q4 202527 Feb 2026 - Q3 2024 net loss narrowed to $56M, but PREPA risks and negative book value persist.MBI
Q3 202412 Feb 2026 - 2024 net loss narrowed, but adjusted losses rose and PREPA uncertainty persists.MBI
Q4 202412 Feb 2026 - Q2 net loss hit $254M on PREPA charges; book value fell to negative $39.07.MBI
Q2 20242 Feb 2026 - Net loss narrowed, PREPA claim marketability improved, but litigation uncertainty persists.MBI
Q2 202523 Nov 2025 - Q1 2025 net loss narrows, PREPA risk remains, statutory capital and liquidity strong.MBI
Q1 202520 Nov 2025 - Q3 net loss narrowed on PREPA claim sales; strong capital and liquidity support future returns.MBI
Q3 202513 Nov 2025